Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hioe

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 22, 2023
Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong KongJ S F Nyaw, K M Cheung, F Hioe, et al.
European Journal of Immunology|August 1, 1996
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunizationC E Allsopp, M Plebanski, S Gilbert, et al.
Plos One|October 2, 2014
Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophagesMichael D Weiden, Satomi Hoshino, David N Levy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2Svenja Weiss, Jéromine Klingler, Catarina Hioe, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivityM K Gorny, T C VanCott, C Hioe, et al.
Journal of Virology|December 20, 2019
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent FusionAlexandra Y Soare, Hagerah S Malik, Natasha D Durham, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
Scientific Reports|November 25, 2025
Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1Jéromine Klingler, Priyanka Gadam Rao, Juan C Bandres, et al.
Scientific Reports|February 3, 2026
Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1Jéromine Klingler, Priyanka Gadam Rao, Juan C Bandres, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 22, 2023
Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong KongJ S F Nyaw, K M Cheung, F Hioe, et al.
European Journal of Immunology|August 1, 1996
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunizationC E Allsopp, M Plebanski, S Gilbert, et al.
Plos One|October 2, 2014
Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophagesMichael D Weiden, Satomi Hoshino, David N Levy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2Svenja Weiss, Jéromine Klingler, Catarina Hioe, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivityM K Gorny, T C VanCott, C Hioe, et al.
Journal of Virology|December 20, 2019
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent FusionAlexandra Y Soare, Hagerah S Malik, Natasha D Durham, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
Scientific Reports|November 25, 2025
Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1Jéromine Klingler, Priyanka Gadam Rao, Juan C Bandres, et al.
Scientific Reports|February 3, 2026
Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1Jéromine Klingler, Priyanka Gadam Rao, Juan C Bandres, et al.
Pageof 16